A lawsuit filed by attorneys on behalf of psychedelic drug developer Reunion Neuroscience alleges that Mindset Pharma “knowingly copied” Reunion’s RE104 (FKA FT-104, when Reunion was part of Field Trip), “and presented that exact composition to the [U.S. Patent and Trademark Office] as its invention.”The dispute, filed on March 13th in the U.S. District Court for the District of New Jersey…
